Structure

Physi-Chem Properties

Molecular Weight:  632.32
Volume:  622.871
LogP:  2.206
LogD:  2.519
LogS:  -4.099
# Rotatable Bonds:  6
TPSA:  172.35
# H-Bond Aceptor:  11
# H-Bond Donor:  4
# Rings:  7
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.248
Synthetic Accessibility Score:  6.139
Fsp3:  0.853
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.588
MDCK Permeability:  4.579450251185335e-05
Pgp-inhibitor:  0.974
Pgp-substrate:  0.996
Human Intestinal Absorption (HIA):  0.913
20% Bioavailability (F20%):  0.131
30% Bioavailability (F30%):  0.989

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.129
Plasma Protein Binding (PPB):  67.61537170410156%
Volume Distribution (VD):  0.676
Pgp-substrate:  9.005722045898438%

ADMET: Metabolism

CYP1A2-inhibitor:  0.006
CYP1A2-substrate:  0.61
CYP2C19-inhibitor:  0.015
CYP2C19-substrate:  0.767
CYP2C9-inhibitor:  0.013
CYP2C9-substrate:  0.012
CYP2D6-inhibitor:  0.003
CYP2D6-substrate:  0.072
CYP3A4-inhibitor:  0.351
CYP3A4-substrate:  0.648

ADMET: Excretion

Clearance (CL):  6.589
Half-life (T1/2):  0.891

ADMET: Toxicity

hERG Blockers:  0.413
Human Hepatotoxicity (H-HT):  0.225
Drug-inuced Liver Injury (DILI):  0.282
AMES Toxicity:  0.159
Rat Oral Acute Toxicity:  0.159
Maximum Recommended Daily Dose:  0.549
Skin Sensitization:  0.523
Carcinogencity:  0.696
Eye Corrosion:  0.003
Eye Irritation:  0.014
Respiratory Toxicity:  0.942

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC231240

Natural Product ID:  NPC231240
Common Name*:   Sitoindoside Ix
IUPAC Name:   n.a.
Synonyms:   sitoindoside IX
Standard InCHIKey:  WKCJIGSUKSPCKI-WNXUODGFSA-N
Standard InCHI:  InChI=1S/C34H48O11/c1-15-11-22(43-30(41)18(15)14-42-31-29(40)28(39)27(38)23(13-35)44-31)16(2)19-5-6-20-17-12-26-34(45-26)25(37)8-7-24(36)33(34,4)21(17)9-10-32(19,20)3/h7-8,16-17,19-23,25-29,31,35,37-40H,5-6,9-14H2,1-4H3/t16-,17-,19+,20-,21-,22+,23+,25-,26+,27+,28-,29+,31+,32+,33-,34+/m0/s1
SMILES:  OC[C@H]1O[C@@H](OCC2=C(C)C[C@@H](OC2=O)[C@H]([C@H]2CC[C@@H]3[C@]2(C)CC[C@H]2[C@H]3C[C@@H]3[C@]4([C@]2(C)C(=O)C=C[C@@H]4O)O3)C)[C@@H]([C@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1934467
PubChem CID:   189586
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0001125] Steroid lactones
          • [CHEMONTID:0001560] Withanolides and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO14874 Physalis longifolia Species Solanaceae Eukaryota aerial parts n.a. n.a. PMID[22098611]
NPO14874 Physalis longifolia Species Solanaceae Eukaryota n.a. aerial part n.a. PMID[22098611]
NPO14874 Physalis longifolia Species Solanaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT169 Cell Line B16-F10 Mus musculus IC50 = 3700.0 nM PMID[501019]
NPT170 Cell Line SK-MEL-28 Homo sapiens IC50 = 8300.0 nM PMID[501019]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 4200.0 nM PMID[501019]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 10000.0 nM PMID[501019]
NPT27 Others Unspecified IC50 = 5200.0 nM PMID[501019]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC231240 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9917 High Similarity NPC316915
0.9669 High Similarity NPC476966
0.9508 High Similarity NPC473593
0.9339 High Similarity NPC3381
0.9333 High Similarity NPC23786
0.9333 High Similarity NPC470265
0.9268 High Similarity NPC245094
0.925 High Similarity NPC67569
0.918 High Similarity NPC318135
0.912 High Similarity NPC173347
0.9113 High Similarity NPC473620
0.9098 High Similarity NPC469789
0.9091 High Similarity NPC129434
0.9083 High Similarity NPC473274
0.904 High Similarity NPC471407
0.9032 High Similarity NPC42399
0.9 High Similarity NPC50774
0.9 High Similarity NPC709
0.8952 High Similarity NPC473635
0.8952 High Similarity NPC293112
0.8934 High Similarity NPC470878
0.8934 High Similarity NPC170084
0.8934 High Similarity NPC476204
0.8934 High Similarity NPC473256
0.8926 High Similarity NPC232258
0.8917 High Similarity NPC286528
0.8917 High Similarity NPC20302
0.8917 High Similarity NPC140055
0.8917 High Similarity NPC167606
0.8898 High Similarity NPC471855
0.8871 High Similarity NPC32868
0.8871 High Similarity NPC8374
0.8871 High Similarity NPC8369
0.8871 High Similarity NPC241456
0.8852 High Similarity NPC474370
0.8843 High Similarity NPC291564
0.881 High Similarity NPC311534
0.879 High Similarity NPC204812
0.879 High Similarity NPC11895
0.878 High Similarity NPC202051
0.877 High Similarity NPC477071
0.877 High Similarity NPC264954
0.876 High Similarity NPC470493
0.876 High Similarity NPC312824
0.876 High Similarity NPC183580
0.876 High Similarity NPC470492
0.875 High Similarity NPC322904
0.875 High Similarity NPC475444
0.875 High Similarity NPC183816
0.875 High Similarity NPC233223
0.875 High Similarity NPC324933
0.875 High Similarity NPC319719
0.875 High Similarity NPC196874
0.875 High Similarity NPC475177
0.875 High Similarity NPC473679
0.873 High Similarity NPC287423
0.873 High Similarity NPC298841
0.872 High Similarity NPC172154
0.872 High Similarity NPC81736
0.871 High Similarity NPC170538
0.871 High Similarity NPC88326
0.871 High Similarity NPC153700
0.8699 High Similarity NPC48692
0.8699 High Similarity NPC476150
0.8699 High Similarity NPC470312
0.8699 High Similarity NPC476127
0.8689 High Similarity NPC45475
0.8689 High Similarity NPC239293
0.8689 High Similarity NPC473828
0.8689 High Similarity NPC473617
0.8678 High Similarity NPC207637
0.8672 High Similarity NPC43589
0.8672 High Similarity NPC300655
0.8672 High Similarity NPC311178
0.8672 High Similarity NPC222951
0.8667 High Similarity NPC122056
0.8661 High Similarity NPC112492
0.8661 High Similarity NPC472270
0.8661 High Similarity NPC23020
0.8661 High Similarity NPC472268
0.8661 High Similarity NPC472269
0.864 High Similarity NPC41129
0.8618 High Similarity NPC473270
0.8618 High Similarity NPC475834
0.8618 High Similarity NPC474179
0.8618 High Similarity NPC476960
0.8607 High Similarity NPC474483
0.8595 High Similarity NPC473882
0.8595 High Similarity NPC147912
0.8595 High Similarity NPC220293
0.8595 High Similarity NPC67259
0.8583 High Similarity NPC470516
0.8571 High Similarity NPC470494
0.856 High Similarity NPC28532
0.856 High Similarity NPC269642
0.855 High Similarity NPC158350
0.8548 High Similarity NPC476961
0.8548 High Similarity NPC281840
0.8548 High Similarity NPC473130
0.8537 High Similarity NPC234522
0.8537 High Similarity NPC186525
0.8537 High Similarity NPC475913
0.8525 High Similarity NPC270929
0.8516 High Similarity NPC45606
0.8516 High Similarity NPC220838
0.8512 High Similarity NPC264153
0.8504 High Similarity NPC174367
0.8504 High Similarity NPC47113
0.8504 High Similarity NPC297950
0.8496 Intermediate Similarity NPC75616
0.8485 Intermediate Similarity NPC289700
0.8485 Intermediate Similarity NPC62172
0.848 Intermediate Similarity NPC204731
0.848 Intermediate Similarity NPC4021
0.848 Intermediate Similarity NPC159456
0.848 Intermediate Similarity NPC46570
0.8468 Intermediate Similarity NPC61520
0.8468 Intermediate Similarity NPC475520
0.8462 Intermediate Similarity NPC155529
0.845 Intermediate Similarity NPC470880
0.845 Intermediate Similarity NPC477235
0.8443 Intermediate Similarity NPC74727
0.8443 Intermediate Similarity NPC475163
0.8438 Intermediate Similarity NPC240070
0.8438 Intermediate Similarity NPC329784
0.8438 Intermediate Similarity NPC117702
0.8438 Intermediate Similarity NPC471357
0.8438 Intermediate Similarity NPC146456
0.8438 Intermediate Similarity NPC473253
0.8438 Intermediate Similarity NPC305496
0.8438 Intermediate Similarity NPC469757
0.843 Intermediate Similarity NPC210420
0.843 Intermediate Similarity NPC236217
0.843 Intermediate Similarity NPC474265
0.8425 Intermediate Similarity NPC470922
0.8421 Intermediate Similarity NPC295885
0.8421 Intermediate Similarity NPC140045
0.8421 Intermediate Similarity NPC596
0.8417 Intermediate Similarity NPC52241
0.8417 Intermediate Similarity NPC475317
0.8417 Intermediate Similarity NPC154856
0.8413 Intermediate Similarity NPC156789
0.8413 Intermediate Similarity NPC107493
0.84 Intermediate Similarity NPC471406
0.84 Intermediate Similarity NPC135369
0.84 Intermediate Similarity NPC241192
0.84 Intermediate Similarity NPC154491
0.84 Intermediate Similarity NPC476962
0.84 Intermediate Similarity NPC268530
0.84 Intermediate Similarity NPC251226
0.8397 Intermediate Similarity NPC247190
0.8397 Intermediate Similarity NPC478151
0.8397 Intermediate Similarity NPC32793
0.8397 Intermediate Similarity NPC469749
0.8397 Intermediate Similarity NPC116075
0.8397 Intermediate Similarity NPC146857
0.8387 Intermediate Similarity NPC475632
0.8387 Intermediate Similarity NPC86020
0.8387 Intermediate Similarity NPC473720
0.8387 Intermediate Similarity NPC329736
0.8385 Intermediate Similarity NPC213634
0.8385 Intermediate Similarity NPC477197
0.8374 Intermediate Similarity NPC268954
0.8374 Intermediate Similarity NPC470075
0.8374 Intermediate Similarity NPC44170
0.8372 Intermediate Similarity NPC476859
0.8372 Intermediate Similarity NPC114306
0.8372 Intermediate Similarity NPC477490
0.8361 Intermediate Similarity NPC473159
0.8361 Intermediate Similarity NPC260665
0.8361 Intermediate Similarity NPC251309
0.8361 Intermediate Similarity NPC73986
0.8358 Intermediate Similarity NPC79250
0.8358 Intermediate Similarity NPC290746
0.8347 Intermediate Similarity NPC285410
0.8347 Intermediate Similarity NPC263827
0.8347 Intermediate Similarity NPC250481
0.8346 Intermediate Similarity NPC141215
0.8346 Intermediate Similarity NPC251998
0.8346 Intermediate Similarity NPC127656
0.8346 Intermediate Similarity NPC471089
0.8346 Intermediate Similarity NPC190065
0.8346 Intermediate Similarity NPC59288
0.8346 Intermediate Similarity NPC160084
0.8346 Intermediate Similarity NPC27363
0.8333 Intermediate Similarity NPC329636
0.8333 Intermediate Similarity NPC471234
0.8321 Intermediate Similarity NPC476193
0.8321 Intermediate Similarity NPC478150
0.8321 Intermediate Similarity NPC478152
0.8321 Intermediate Similarity NPC478154
0.8321 Intermediate Similarity NPC478153
0.832 Intermediate Similarity NPC475041
0.832 Intermediate Similarity NPC161065
0.832 Intermediate Similarity NPC122971
0.832 Intermediate Similarity NPC473203
0.8309 Intermediate Similarity NPC48414
0.8309 Intermediate Similarity NPC5153
0.8308 Intermediate Similarity NPC471358
0.8308 Intermediate Similarity NPC6108

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC231240 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8917 High Similarity NPD7115 Discovery
0.8333 Intermediate Similarity NPD7503 Approved
0.8308 Intermediate Similarity NPD7319 Approved
0.8217 Intermediate Similarity NPD7507 Approved
0.8189 Intermediate Similarity NPD8033 Approved
0.8189 Intermediate Similarity NPD8513 Phase 3
0.811 Intermediate Similarity NPD8377 Approved
0.811 Intermediate Similarity NPD8294 Approved
0.8099 Intermediate Similarity NPD6686 Approved
0.8092 Intermediate Similarity NPD7736 Approved
0.8062 Intermediate Similarity NPD8328 Phase 3
0.8047 Intermediate Similarity NPD8335 Approved
0.8047 Intermediate Similarity NPD8517 Approved
0.8047 Intermediate Similarity NPD8380 Approved
0.8047 Intermediate Similarity NPD8378 Approved
0.8047 Intermediate Similarity NPD8296 Approved
0.8047 Intermediate Similarity NPD8379 Approved
0.8047 Intermediate Similarity NPD8515 Approved
0.8047 Intermediate Similarity NPD8516 Approved
0.7953 Intermediate Similarity NPD7327 Approved
0.7953 Intermediate Similarity NPD7328 Approved
0.792 Intermediate Similarity NPD8133 Approved
0.7891 Intermediate Similarity NPD7516 Approved
0.7886 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.7869 Intermediate Similarity NPD6412 Phase 2
0.7846 Intermediate Similarity NPD6370 Approved
0.7744 Intermediate Similarity NPD8293 Discontinued
0.7734 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.7727 Intermediate Similarity NPD7492 Approved
0.7692 Intermediate Similarity NPD6054 Approved
0.7692 Intermediate Similarity NPD6319 Approved
0.7669 Intermediate Similarity NPD6616 Approved
0.7612 Intermediate Similarity NPD7078 Approved
0.7559 Intermediate Similarity NPD8297 Approved
0.7559 Intermediate Similarity NPD6882 Approved
0.75 Intermediate Similarity NPD6016 Approved
0.75 Intermediate Similarity NPD6015 Approved
0.748 Intermediate Similarity NPD8413 Clinical (unspecified phase)
0.7462 Intermediate Similarity NPD6009 Approved
0.746 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7444 Intermediate Similarity NPD5988 Approved
0.7438 Intermediate Similarity NPD4225 Approved
0.7424 Intermediate Similarity NPD6059 Approved
0.7402 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.7377 Intermediate Similarity NPD7639 Approved
0.7377 Intermediate Similarity NPD7640 Approved
0.7364 Intermediate Similarity NPD4632 Approved
0.7344 Intermediate Similarity NPD6650 Approved
0.7344 Intermediate Similarity NPD6649 Approved
0.7295 Intermediate Similarity NPD7638 Approved
0.7266 Intermediate Similarity NPD6371 Approved
0.7244 Intermediate Similarity NPD6899 Approved
0.7244 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7244 Intermediate Similarity NPD6881 Approved
0.7226 Intermediate Similarity NPD8074 Phase 3
0.7222 Intermediate Similarity NPD6008 Approved
0.7209 Intermediate Similarity NPD8130 Phase 1
0.7188 Intermediate Similarity NPD6373 Approved
0.7188 Intermediate Similarity NPD6372 Approved
0.7165 Intermediate Similarity NPD5954 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD5697 Approved
0.7132 Intermediate Similarity NPD6883 Approved
0.7132 Intermediate Similarity NPD4634 Approved
0.7132 Intermediate Similarity NPD7102 Approved
0.7132 Intermediate Similarity NPD7604 Phase 2
0.7132 Intermediate Similarity NPD7290 Approved
0.7087 Intermediate Similarity NPD6402 Approved
0.7087 Intermediate Similarity NPD5739 Approved
0.7087 Intermediate Similarity NPD6675 Approved
0.7087 Intermediate Similarity NPD7128 Approved
0.7077 Intermediate Similarity NPD6869 Approved
0.7077 Intermediate Similarity NPD6617 Approved
0.7077 Intermediate Similarity NPD6847 Approved
0.7073 Intermediate Similarity NPD7902 Approved
0.7054 Intermediate Similarity NPD6014 Approved
0.7054 Intermediate Similarity NPD6012 Approved
0.7054 Intermediate Similarity NPD6013 Approved
0.704 Intermediate Similarity NPD5344 Discontinued
0.7025 Intermediate Similarity NPD6399 Phase 3
0.7016 Intermediate Similarity NPD8029 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD6698 Approved
0.7 Intermediate Similarity NPD46 Approved
0.6985 Remote Similarity NPD5983 Phase 2
0.6984 Remote Similarity NPD5211 Phase 2
0.6977 Remote Similarity NPD6011 Approved
0.6977 Remote Similarity NPD7320 Approved
0.6967 Remote Similarity NPD7748 Approved
0.6929 Remote Similarity NPD6033 Approved
0.6906 Remote Similarity NPD6336 Discontinued
0.6899 Remote Similarity NPD5701 Approved
0.6899 Remote Similarity NPD7899 Clinical (unspecified phase)
0.6894 Remote Similarity NPD6053 Discontinued
0.6884 Remote Similarity NPD6067 Discontinued
0.6875 Remote Similarity NPD5141 Approved
0.685 Remote Similarity NPD7632 Discontinued
0.6829 Remote Similarity NPD7900 Approved
0.6829 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6825 Remote Similarity NPD5285 Approved
0.6825 Remote Similarity NPD5286 Approved
0.6825 Remote Similarity NPD4696 Approved
0.6803 Remote Similarity NPD7515 Phase 2
0.6803 Remote Similarity NPD6079 Approved
0.68 Remote Similarity NPD6083 Phase 2
0.68 Remote Similarity NPD6084 Phase 2
0.6788 Remote Similarity NPD7799 Discontinued
0.6783 Remote Similarity NPD7260 Phase 2
0.6763 Remote Similarity NPD7829 Approved
0.6763 Remote Similarity NPD7642 Approved
0.6763 Remote Similarity NPD7830 Approved
0.6744 Remote Similarity NPD8170 Clinical (unspecified phase)
0.6739 Remote Similarity NPD6921 Approved
0.6721 Remote Similarity NPD7838 Discovery
0.6721 Remote Similarity NPD5785 Approved
0.6719 Remote Similarity NPD5224 Approved
0.6719 Remote Similarity NPD5225 Approved
0.6719 Remote Similarity NPD5226 Approved
0.6719 Remote Similarity NPD4633 Approved
0.6715 Remote Similarity NPD7100 Approved
0.6715 Remote Similarity NPD7101 Approved
0.6713 Remote Similarity NPD5956 Approved
0.6693 Remote Similarity NPD6648 Approved
0.6692 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5175 Approved
0.6667 Remote Similarity NPD4755 Approved
0.6667 Remote Similarity NPD8035 Phase 2
0.6667 Remote Similarity NPD8034 Phase 2
0.6667 Remote Similarity NPD3618 Phase 1
0.6667 Remote Similarity NPD7637 Suspended
0.6667 Remote Similarity NPD5174 Approved
0.6642 Remote Similarity NPD6335 Approved
0.6641 Remote Similarity NPD5223 Approved
0.664 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6639 Remote Similarity NPD5328 Approved
0.6621 Remote Similarity NPD8338 Approved
0.6618 Remote Similarity NPD6274 Approved
0.6614 Remote Similarity NPD5696 Approved
0.6613 Remote Similarity NPD4202 Approved
0.6601 Remote Similarity NPD7625 Phase 1
0.6591 Remote Similarity NPD4730 Approved
0.6591 Remote Similarity NPD4729 Approved
0.6587 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6587 Remote Similarity NPD5221 Approved
0.6587 Remote Similarity NPD5222 Approved
0.6573 Remote Similarity NPD8337 Approved
0.6573 Remote Similarity NPD8336 Approved
0.6569 Remote Similarity NPD6317 Approved
0.6562 Remote Similarity NPD4700 Approved
0.6535 Remote Similarity NPD5173 Approved
0.6532 Remote Similarity NPD7983 Approved
0.6529 Remote Similarity NPD3574 Clinical (unspecified phase)
0.6522 Remote Similarity NPD6314 Approved
0.6522 Remote Similarity NPD6313 Approved
0.6508 Remote Similarity NPD4629 Approved
0.6508 Remote Similarity NPD5210 Approved
0.6508 Remote Similarity NPD5695 Phase 3
0.65 Remote Similarity NPD4786 Approved
0.65 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6496 Remote Similarity NPD6868 Approved
0.6493 Remote Similarity NPD5249 Phase 3
0.6493 Remote Similarity NPD5248 Approved
0.6493 Remote Similarity NPD5251 Approved
0.6493 Remote Similarity NPD5247 Approved
0.6493 Remote Similarity NPD5250 Approved
0.648 Remote Similarity NPD5779 Approved
0.648 Remote Similarity NPD5778 Approved
0.6475 Remote Similarity NPD3573 Approved
0.6457 Remote Similarity NPD4697 Phase 3
0.6446 Remote Similarity NPD1694 Approved
0.6443 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6439 Remote Similarity NPD4767 Approved
0.6439 Remote Similarity NPD4768 Approved
0.6434 Remote Similarity NPD8451 Approved
0.6423 Remote Similarity NPD5737 Approved
0.6423 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6423 Remote Similarity NPD6672 Approved
0.64 Remote Similarity NPD5281 Approved
0.64 Remote Similarity NPD5284 Approved
0.64 Remote Similarity NPD5693 Phase 1
0.64 Remote Similarity NPD6411 Approved
0.6395 Remote Similarity NPD6845 Suspended
0.6393 Remote Similarity NPD7334 Approved
0.6393 Remote Similarity NPD6684 Approved
0.6393 Remote Similarity NPD5330 Approved
0.6393 Remote Similarity NPD7521 Approved
0.6393 Remote Similarity NPD7146 Approved
0.6393 Remote Similarity NPD6409 Approved
0.6389 Remote Similarity NPD8448 Approved
0.6383 Remote Similarity NPD6908 Approved
0.6383 Remote Similarity NPD6909 Approved
0.6378 Remote Similarity NPD1698 Clinical (unspecified phase)
0.6371 Remote Similarity NPD4753 Phase 2
0.637 Remote Similarity NPD8391 Approved
0.637 Remote Similarity NPD8390 Approved
0.637 Remote Similarity NPD8392 Approved
0.6364 Remote Similarity NPD8299 Approved
0.6364 Remote Similarity NPD8341 Approved
0.6364 Remote Similarity NPD8340 Approved
0.6364 Remote Similarity NPD6400 Clinical (unspecified phase)
0.6364 Remote Similarity NPD8342 Approved
0.6357 Remote Similarity NPD4522 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data